Investors have taken a close look at a potential deal.

The Swiss Franc is getting crushed.

A deal with NBCUniversal nearly doubles the popular website’s valuation.

Despite the controversy engulfing Planned Parenthood, corporate donors haven’t backed off. “Our support is stronger and stronger, instead of backing away,” says one.

Allergan, a company shaped by five major deals since 2012, is a symbol of the pharmaceutical industry’s recent merger-mania.

The bank’s investment banking business, which is its big problem, was also its major engine of growth. Earnings this quarter were good. But the path forward is still unclear.

The Justice Dept. wants the Supreme court to overturn a ruling that made prosecuting insider trading harder.

Flat markets, like the one we are in right now, do not suggest any particular outcome when the S&P 500 finally breaks out of its slumber.